Walther Louise Houlberg, Mieritz Hanne Beck, Lassen Annmarie Touborg, Christensen Erika Frischknecht, Mogensen Christian Backer, Mikkelsen Søren, Brøchner Anne Craveiro
The Prehospital Research Unit, Region of Southern Denmark, Odense University Hospital, J. B. Winsloews Vej 4, 5000, Odense C, Denmark.
Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
Scand J Trauma Resusc Emerg Med. 2024 Dec 26;32(1):137. doi: 10.1186/s13049-024-01310-1.
The prehospital use of blood lactate measurements is increasing. However, the test's benefits have not been methodically evaluated in non-trauma patients. This study had three aims: (1) To assess the evidence of prehospital blood lactate measurements' prognostic value in non-trauma patients, (2) to investigate to what extent the test changed early patient treatment, and (3) to evaluate the healthcare personnel's attitude towards the test.
MEDLINE, Embase, and Cochrane Central Register of Controlled Trials were systematically searched until Aug 26, 2023. Cohort and randomized controlled trials assessing ≥ 20 acute non-trauma patients with prehospital lactate measurements were included if they reported (1) prognostic outcomes such as short-term mortality or (2) changes in early patient treatments. All study designs were included to assess (3) the healthcare personnel's opinion on prehospital lactate measurements. The risks of bias were assessed using the QUIPS tool, the Newcastle-Ottawa Scale, and the RoB-2. Study registration number CRD42020167169 (PROSPERO).
We screened 6028 study reports. We included 15 studies on (1) the prognostic value of prehospital lactate measurements. Elevated blood lactate levels were correlated to a higher short-term mortality risk in most of the studies but not in studies with out-of-hospital cardiac arrest (OHCA) patients. The 15 prognostic studies were all cohort studies with moderate or high risks of bias. Four studies investigated (2) early treatment changes. They found that the prehospital lactate measurement may have changed early treatment in sepsis patients. However, all four studies on treatment changes were at high risk of bias. Four studies were included on (3) the healthcare personnel's attitude towards the lactate measurement. Evidence of the healthcare personnel's opinion on prehospital lactate measurements was scarce.
Most acute non-trauma patients with elevated prehospital lactate levels had increased risks of short-term mortality, except OHCA patients. Few studies suggested that measuring prehospital lactate levels could change early patient care, particularly in patients with suspected sepsis. The certainty of the evidence is low in this systematic review. The included studies were heterogeneous, and many had high risks of bias. Further studies are needed to investigate the impact of prehospital lactate measurements on patient care.
院前血液乳酸测定的应用正在增加。然而,该检测在非创伤患者中的益处尚未得到系统评估。本研究有三个目的:(1)评估院前血液乳酸测定在非创伤患者中的预后价值证据;(2)调查该检测在多大程度上改变了患者的早期治疗;(3)评估医护人员对该检测的态度。
系统检索MEDLINE、Embase和Cochrane对照试验中心注册库,检索截至2023年8月26日的文献。纳入评估≥20例急性非创伤患者院前乳酸测定的队列研究和随机对照试验,条件为这些研究报告了(1)短期死亡率等预后结局,或(2)早期患者治疗的变化。纳入所有研究设计以评估(3)医护人员对院前乳酸测定的看法。使用QUIPS工具、纽卡斯尔-渥太华量表和RoB-2评估偏倚风险。研究注册号CRD42020167169(PROSPERO)。
我们筛选了6028篇研究报告。纳入了15项关于(1)院前乳酸测定预后价值的研究。在大多数研究中,血液乳酸水平升高与短期死亡风险较高相关,但在院外心脏骤停(OHCA)患者的研究中并非如此。这15项预后研究均为队列研究,存在中度或高度偏倚风险。四项研究调查了(2)早期治疗变化。他们发现院前乳酸测定可能改变了脓毒症患者的早期治疗。然而,所有四项关于治疗变化的研究均存在高偏倚风险。纳入了四项关于(3)医护人员对乳酸测定态度的研究。关于医护人员对院前乳酸测定看法的证据很少。
除OHCA患者外,大多数院前乳酸水平升高的急性非创伤患者短期死亡风险增加。少数研究表明,测定院前乳酸水平可能改变患者的早期护理,尤其是疑似脓毒症患者。本系统评价中的证据确定性较低。纳入的研究具有异质性,许多研究存在高偏倚风险。需要进一步研究以调查院前乳酸测定对患者护理的影响。